symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
AMPE,3.15,1.788109,36182,2378527,0,2.65-13.2,-0.01,"Ampio Pharmaceuticals, Inc.",USD,0001411906,US03209T1097,03209T109,American Stock Exchange,AMEX,Biotechnology,https://www.ampiopharma.com,"Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation; AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19; and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. The company is headquartered in Englewood, Colorado.",Mr. Michael A. Martino,Healthcare,US,8,720 437 6500,373 Inverness Parkway,Englewood,CO,80112,,1.115,https://financialmodelingprep.com/image-stock/AMPE.png,2010-03-31,False,False,True,False,False
